Compare Astar (ASTR) vs Enzyme (MLN) Price & Performance

Astar (ASTR) is currently trading at Rp81.261, exhibiting a bearish technical signal with moving averages indicating strong selling pressure, though oscillators show a neutral to slightly bullish divergence. The token's circulating supply is 8.7M out of a max 10M, with an average hold time of 53 days. Recent technical indicators highlight oversold conditions with RSI levels at 11.37 (6-day) and 22.57 (12-day), suggesting potential for a near-term rebound, while ADX readings indicate a strong trend. No major protocol updates or ecosystem news were identified in the immediate period.

Overall outlook is cautious with a bearish bias; key opportunities lie in oversold RSI levels hinting at a technical bounce, while major risks include persistent selling pressure, low liquidity, and the inherent volatility of a low-market-cap crypto asset. Investors should monitor key support at Rp77 and resistance at Rp83 closely.

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.